CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation?

Psychopharmacology (Berl). 2007 Feb;190(2):265-8. doi: 10.1007/s00213-006-0629-3. Epub 2006 Nov 22.
No abstract available

MeSH terms

  • Clinical Trials as Topic / legislation & jurisprudence*
  • Diffusion of Innovation*
  • Drug Approval / legislation & jurisprudence*
  • Drug-Related Side Effects and Adverse Reactions
  • Europe
  • European Union*
  • Humans
  • Psychotropic Drugs / adverse effects
  • Psychotropic Drugs / therapeutic use*
  • Quality Assurance, Health Care / legislation & jurisprudence
  • Treatment Outcome

Substances

  • Psychotropic Drugs